Оптимизация терапии нетяжелой внебольничной пневмонии у больных с факторами риска. Клинико-экономический анализ
Молчанова Ольга Владимировна, Salavat Sh. Suleymanov, Островский Анатолий Борисович et al. · Dalʹnevostočnyj medicinskij žurnal · 2009
According to the received data during hospital treatment of community acquired noncomplicated pneumonia for patients with risk factors the following scheme of antibiotic therapy is beneficial: beta lactam (cefotaximi/ceftriaxone) in combination with macrolides (azithromycin). Suggested therapy provides statistically lower percent of unfavorable course of pneumonias and decreases expenditures for their treatment.
Cited by 0 works.